Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w108
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Perceptive Advisors | 7.1M | $10M | 0% | Sep 2024 |
|
Vanguard Group | 1.3M | $9.3M | 0% | Jun 2024 |
|
BlackRock | 1.1M | $8.2M | 1% | Jun 2024 |
|
BlackRock | 1.1M | $1.6M | 100% | Sep 2024 |
|
Geode Capital Management | 456k | $661k | -2% | Sep 2024 |
|
State Street Corporation | 452k | $3.3M | 9% | Jun 2024 |
|
Propel Bio Management | 425k | $3.1M | 100% | Jun 2024 |
|
Northern Trust | 219k | $318k | 10% | Sep 2024 |
|
Simplify Asset Management | 200k | $290k | -29% | Sep 2024 |
|
ExodusPoint Capital Management | 186k | $270k | 100% | Sep 2024 |
|
BML Capital Management | 180k | $261k | 0% | Sep 2024 |
|
Renaissance Technologies | 148k | $215k | 225% | Sep 2024 |
|
Steel Peak Wealth Management | 102k | $148k | -17% | Sep 2024 |
|
Kovitz Investment Group Partners | 101k | $147k | 1% | Sep 2024 |
|
Nuveen Asset Management | 95k | $693k | 0% | Jun 2024 |
|
Mariner Wealth Advisors | 90k | $130k | 414% | Sep 2024 |
|
Morgan Stanley | 85k | $619k | -37% | Jun 2024 |
|
Miracle Mile Advisors | 84k | $122k | 0% | Sep 2024 |
|
Bridgeway Capital Management | 82k | $599k | 0% | Jun 2024 |
|
Beck Mack & Oliver | 70k | $102k | 133% | Sep 2024 |
|
Jane Street | 70k | $101k | 106% | Sep 2024 |
|
Charles Schwab Investment Management | 51k | $74k | 0% | Sep 2024 |
|
Hrt Financial | 49k | $70k | 100% | Sep 2024 |
|
Bank of New York Mellon | 44k | $63k | -26% | Sep 2024 |
|
Two Sigma Investments | 43k | $312k | 71% | Jun 2024 |
|
Bank of America Corporation | 32k | $47k | 10% | Sep 2024 |
|
Barclays | 31k | $45k | 405% | Sep 2024 |
|
SPC Financial | 30k | $44k | 0% | Sep 2024 |
|
Susquehanna International | 28k | $41k | 42% | Sep 2024 |
|
Royal Bank of Canada | 26k | $37k | 824% | Sep 2024 |
|
Sherbrooke Park Advisers | 25k | $36k | 100% | Sep 2024 |
|
Rhumbline Advisers | 25k | $36k | -7% | Sep 2024 |
|
Creative Planning | 19k | $28k | -36% | Sep 2024 |
|
Stifel Financial | 17k | $127k | -15% | Jun 2024 |
|
Engineers Gate Manager | 17k | $24k | 100% | Sep 2024 |
|
Citadel Advisors | 16k | $24k | -53% | Sep 2024 |
|
SG Americas Securities | 14k | $21k | 100% | Sep 2024 |
|
Citigroup | 14k | $20k | 204% | Sep 2024 |
|
Alliancebernstein | 12k | $89k | 100% | Jun 2024 |
|
Cambridge Investment Research Advisors | 12k | $17k | 0% | Sep 2024 |
|
Branch Banking & Trust Company | 11k | $77k | 0% | Jun 2024 |
|
Mirae Asset Global Etfs Holdings | 10k | $15k | -9% | Sep 2024 |
|
FinTrust Capital Advisors | 10k | $15k | 100% | Sep 2024 |
|
Key FInancial | 9.4k | $14k | 0% | Sep 2024 |
|
New York State Common Retirement Fund | 9.1k | $13k | 0% | Sep 2024 |
|
Jpmorgan Chase & Co | 8.9k | $13k | 3% | Sep 2024 |
|
Wells Fargo & Company | 5.8k | $8.5k | -4% | Sep 2024 |
|
Spire Wealth Management | 5.7k | $8.2k | 0% | Sep 2024 |
|
Tower Research Capital | 4.7k | $34k | 207% | Jun 2024 |
|
Bnp Paribas Arbitrage, Snc | 4.3k | $6.2k | 162% | Sep 2024 |
|
Salomon & Ludwin | 2.9k | $4.2k | 0% | Sep 2024 |
|
Simplex Trading | 2.4k | $3.0k | 100% | Sep 2024 |
|
Summit Investment Advisors | 1.7k | $2.5k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 1.4k | $2.0k | 0% | Sep 2024 |
|
Advisor Group Holdings | 768.00 | $1.1k | 668% | Sep 2024 |
|
Amalgamated Bank | 704.00 | $1.0k | 0% | Sep 2024 |
|
Russell Investments | 620.00 | $4.5k | 773% | Jun 2024 |
|
Deutsche Bank Aktiengesellschaft | 591.00 | $857.009100 | -100% | Sep 2024 |
|
Pnc Financial Services | 467.00 | $677.009900 | 110% | Sep 2024 |
|
SRS Capital Advisors | 241.00 | $350.004300 | 0% | Sep 2024 |
|
Coastline Trust | 200.00 | $290.000000 | 100% | Sep 2024 |
|
Coppell Advisory Solutions | 200.00 | $338.000000 | 0% | Sep 2024 |
|
Macquarie Group | 88.00 | $642.004000 | 100% | Jun 2024 |
|
NISA Investment Advisors | 75.00 | $108.997500 | 121% | Sep 2024 |
|
Jones Financial Companies, L.L | 73.00 | $122.997700 | 100% | Sep 2024 |
|
Carmichael Hill & Associates | 21.00 | $31.000200 | 0% | Sep 2024 |
|
CWM | 20.00 | $0 | 43% | Sep 2024 |
|
Sterling Capital Management | 19.00 | $28.000300 | 100% | Sep 2024 |
|
Who sold out of Verrica Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Invesco | Jun 2024 | 424k | $3.1M |
Kornitzer Capital Management | Jun 2024 | 74k | $541k |
Eudaimonia Asset Management | Jun 2024 | 71k | $515k |
J. Goldman & Co | Mar 2024 | 27k | $160k |
Goldman Sachs Group | Mar 2024 | 20k | $116k |
MetLife Investment Advisors | Jun 2024 | 12k | $87k |
Quest Partners | Jun 2024 | 6.9k | $51k |
Cetera Trust Company | Jun 2024 | 1.0k | $7.3k |
Parallel Advisors | Jun 2024 | 176.00 | $1.3k |
Brian McDonald | Jun 2024 | 158.00 | $1.2k |
Quadrant Capital | Jun 2024 | 110.00 | $801.999000 |
GAMMA Investing | Jun 2024 | 38.00 | $277.001000 |
Farther Finance Advisors | Jun 2024 | 31.00 | $246.000500 |